Want to join the conversation?
During 2Q16, $CVS' consolidated operating profit rose 3.9% vs. 2Q15. In the Pharmacy Services segment, operating profit jumped by $98MM, or 10.4% and in the Retail/LTC segment, operating profit rose by $24MM, or 1.4%. The company said that both segments benefited from the Omnicare acquisition and increased generic drugs dispensed.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?